Gloves, gowns and masks for reducing the transmission of meticillin-resistant Staphylococcus aureus (MRSA) in the hospital setting

Cochrane Database of Systematic Reviews

Volumn 2015, Issue 7, 2015, Pages

  López Alcalde, Jesús ^a   Mateos Mazón, Marta ^b   Guevara, Marcela ^c   Conterno, Lucieni O ^d   Solà, Ivan ^a   Cabir Nunes, Sheila ^e   Bonfill Cosp, Xavier ^a  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^b HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

^c INSTITUTO DE SALUD PÚBLICA DE NAVARRA   (Spain)

^d Marilia Medical School   (Brazil)

^e Independent consultant   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALL CAUSE MORTALITY; BACTERIAL TRANSMISSION; CAREGIVER; CLINICAL EFFECTIVENESS; DRUG USE; HOSPITAL PATIENT; HOSPITAL PERSONNEL; HUMAN; LENGTH OF STAY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; METHICILLIN SUSCEPTIBLE STAPHYLOCOCCUS AUREUS; MICROBIAL COLONIZATION; MORTALITY; PATIENT VISITOR; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SYSTEMATIC REVIEW; CROSS INFECTION; FEMALE; MASK; PROTECTIVE CLOTHING; STAPHYLOCOCCAL INFECTIONS; TRANSMISSION;

CROSS INFECTION; FEMALE; GLOVES, PROTECTIVE; HUMANS; MASKS; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; PROTECTIVE CLOTHING; STAPHYLOCOCCAL INFECTIONS;

EID: 84957425996     PISSN: None     EISSN: 1469493X     Source Type: Journal    
DOI: 10.1002/14651858.CD007087.pub2     Document Type: Review

References (272)

1. Agbayani M, Rosenfeld W, Evans H, Salazar D, Jhaveri R, Braun J. Evaluation of modified gowning procedures in a neonatal intensive care unit. American Journal of Diseases of Children 1981;135(7):650-2.
2. Álvarez-Lerma F, Gasulla Guillermo M, Abad Peruga V, Pueyo Pont MJ, Tarrago Eixarch E. Effectiveness of contact isolation in the control of multiresistant bacteria in an intensive care service [Efectividad del aislamiento de contacto en el control de bacterias multirresistentes en un servicio de medicina intensiva.]. Enfermedades Infecciosas y Microbiologia Clínica 2002;20(2):57-63.
3. Assadian O, Kramer A, Ouriel K, Suchomel M, McLaws ML, Rottman M, et al. Suppression of surgeons' bacterial hand flora during surgical procedures with a new antimicrobial surgical glove. Surgical Infections 2014;15(1):43-9.
4. Batra R, Cooper BS, Whiteley C, Patel AK, Wyncoll D, Edgeworth JD. Efficacy and limitation of a chlorhexidine-based decolonization strategy in preventing transmission of methicillin-resistant Staphylococcus aureus in an intensive care unit. Clinical Infectious Diseases: an Official Publication of the Infectious Diseases Society of America 2010;50(2):210-7.
5. Bearman GM, Marra AR, Sessler CN, Smith WR, Rosato A, Laplante JK, et al. A controlled trial of universal gloving versus contact precautions for preventing the transmission of multidrug-resistant organisms. American Journal of Infection Control 2007;35(10):650-5.
6. Bearman G, Rosato AE, Duane TM, Elam K, Sanogo K, Haner C, et al. Trial of universal gloving with emollient-impregnated gloves to promote skin health and prevent the transmission of multidrug-resistant organisms in a surgical intensive care unit. Infection Control and Hospital Epidemiology: the Official Journal of the Society of Hospital Epidemiologists of America 2010;31(5):491-7.
7. Bertrand X, Lopez-Lozano JM, Slekovec C, Thouverez M, Hocquet D, Talon D. Temporal effects of infection control practices and the use of antibiotics on the incidence of MRSA. The Journal of Hospital Infection 2012;82(3):164-9.
8. BischoffWE, Tucker BK, Wallis ML, Reboussin BA, Pfaller MA, Hayden FG, et al. Preventing the airborne spread of Staphylococcus aureus by persons with the common cold: effect of surgical scrubs, gowns, and masks. Infection Control and Hospital Epidemiology: the Official Journal of the Society of Hospital Epidemiologists of America 2007;28(10):1148-54.
9. Boyce JM, Chenevert C. Isolation gowns prevent health care workers (HCWs) from contaminating their clothing, and possibly their hands, with methicillin-resistant Staphylococcus aureus (MRSA) and resistant enterococci. Infection Control and Hospital Epidemiology 1998;19(9):74.
10. Croft L, Harris AD, Pineles L, Langenberg P, Shardell M, Simoni-Wastila L, Morgan D. The effect of universal glove and gown use on adverse events in the benefits of universal glove and gown (BUGG) cluster randomized trial. IDWeek, 2014: https://idsa.confex.com/idsa/2014/webprogram/Paper46927.html (accessed 27 June 2015).
11. Harris AD, Pineles L, Belton B, Johnson J K, Shardell M, Loeb M, et al. Universal glove and gown use and acquisition of antibiotic-resistant bacteria in the ICU: a randomized trial. JAMA 2013;310(15):1571-80.
12. Harris AD, Pineles L, Belton B, Johnson K, Shardell M, Loeb M, et al. The benefits of universal glove and gown (BUGG) use on the acquisition of antibiotic-resistant bacteria: a cluster randomized trial. IDWeek, 2013: https://idsa.confex.com/idsa/2013/webprogram/Paper42208.html (accessed 3 Sept 2014).
13. Kett D, Morgan DJ, Pineles L, Zervos MJ, Munoz-Price LS, Harris AD, BUGG Investigators. Compliance with the implementation of an ICU cluster-randomized trial assessing the benefits and potential harms of universal glove and gowning. Critical Care 2013;17(Suppl 2):54.
14. Burden M, Cervantes L, Weed D, Keniston A, Price CS, Albert RK. Newly cleaned physician uniforms and infrequently washed white coats have similar rates of bacterial contamination after an 8-hour workday: a randomized controlled trial. Journal of Hospital Medicine: an Official Publication of the Society of Hospital Medicine 2011;6(4):177-82.
15. Camus C, Bellissant E, Legras A, Renault A, Gacouin A, Lavoue S, et al. Randomized comparison of 2 protocols to prevent acquisition of methicillin-resistant Staphylococcus aureus: results of a 2-center study involving 500 patients. Infection Control and Hospital Epidemiology: the Official Journal of the Society of Hospital Epidemiologists of America 2011;32(11):1064-72.
16. Duquette-Petersen L, Francis ME, Dohnalek L, Skinner R, Dudas P. The role of protective clothing in infection prevention in patients undergoing autologous bone marrow transplantation. Oncology Nursing Forum 1999;26(8):1319-24.
17. Ellingson K, Muder RR, Jain R, Kleinbaum D, Feng PJ, Cunningham C, et al. Sustained reduction in the clinical incidence of methicillin-resistant Staphylococcus aureus colonization or infection associated with a multifaceted infection control intervention. Infection Control and Hospital Epidemiology: the Official Journal of the Society of Hospital Epidemiologists of America 2011;32(1):1-8.
18. Evans ME, Kralovic SM, Simbartl LA, Obrosky DS, Hammond MC, Goldstein B, et al. Prevention of methicillin-resistant Staphylococcus aureus infections in spinal cord injury units. American Journal of Infection Control 2013;41(5):422-6.
19. Eveillard M, Eb F, Tramier B, Schmit JL, Lescure FX, Biendo M, et al. Evaluation of the contribution of isolation precautions in prevention and control of multi-resistant bacteria in a teaching hospital. The Journal of Hospital Infection 2001;47(2):116-24.
20. Gandra S, Barysauskas CM, Mack DA, Barton B, Finberg R, Ellison RT 3rd. Impact of contact precautions on falls, pressure ulcers and transmission of MRSA and VRE in hospitalized patients. The Journal of Hospital Infection 2014;88(3):170-6.
21. Gilmore DS, Montgomerie JZ, Graham IE. Category 1, 2, 3 and 4: a procedure-oriented isolation system. Infection Control 1986;7(5):263-7.
22. Gilroy SA, Miller Stahl B, Noonan C, Susman R, Johnson L, Kullman M, et al. Reduction of hospital-acquired methicillin-resistant Staphylococcus aureus infection by cohorting patients in a dedicated unit. Infection Control and Hospital Epidemiology: the Official Journal of the Society of Hospital Epidemiologists of America 2009; Vol. 30, issue 2:203-5.
23. Grant J, Ramman-Haddad L, Dendukuri N, Libman MD. The role of gowns in preventing nosocomial transmission of methicillin-resistant Staphylococcus aureus (MRSA): gown use in MRSA control. Infection Control and Hospital Epidemiology: the Official Journal of the Society of Hospital Epidemiologists of America 2006;27(2):191-4.
24. Ho ML, Seto WH, Wong LC, Wong TY. Effectiveness of multifaceted hand hygiene interventions in long-term care facilities in Hong Kong: a cluster-randomized controlled trial. Infection Control and Hospital Epidemiology: the Official Journal of the Society of Hospital Epidemiologists of America 2012;33(8):761-7.
25. Huang YC, Lien RI, Su LH, Chou YH, Lin TY. Successful control of methicillin-resistant Staphylococcus aureus in endemic neonatal intensive care units - a 7-year campaign. PloS one 2011;6(8):e23001.
26. Jain R, Kralovic SM, Evans ME, Ambrose M, Simbartl LA, Obrosky DS, et al. Veterans Affairs initiative to prevent methicillin-resistant Staphylococcus aureus infections. The New England Journal of Medicine 2011;364(15):1419-30.
27. Kappstein I, van der Muhlen K, Meschzan D, Vatou V, Bieg-Habermann S. Prevention of transmission of methicillin-resistant Staphylococcus aureus (MRSA) infection: standard precautions instead of isolation: a 6-year surveillance in a university hospital [Pravention von MRSA-Ubertragungen: Standardhygiene statt Isolierung: 6 Jahre Uberwachung in einem Universitatsklinikum]. Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen 2009;80(1):49-61.
28. Kaufman DA, Blackman A, Conaway MR, Sinkin RA. Nonsterile glove use in addition to hand hygiene to prevent late-onset infection in preterm infants: randomized clinical trial. JAMA pediatrics 2014;168(10):909-16.
29. KirklandK B, Ptak JA, Dugan EA, Smith RH. A voice crying out in the wilderness? Sustained control of healthcare-associated MRSA infection without screening or organism-based isolation [abstract 23]. Presented at the 17th Annual Scientific Meeting of the Society for Healthcare Epidemiology of America;. Baltimore, 2007 April 14-17; Baltimore.
30. Klein BS, PerloffWH, Maki DG. Reduction of nosocomial infection during pediatric intensive care by protective isolation. The New England Journal of Medicine 1989;320(26):1714-21.
31. Koss WG, Khalili TM, Lemus JF, Chelly MM, Margulies DR, Shabot MM. Nosocomial pneumonia is not prevented by protective contact isolation in the surgical intensive care unit. The American Surgeon 2001;67(12):1140-4.
32. Lacey S, Flaxman D, Scales J, Wilson A. The usefulness of masks in preventing transient carriage of epidemic methicillin-resistant Staphylococcus aureus by healthcare workers. The Journal of Hospital Infection 2001;48(4):308-11.
33. Maki DG, Zilz MA, Mccormick R. The effectiveness of using preemptive barrier precautions routinely (protective isolation) in all high-risk patients to prevent nosocomial infection with resistant organisms, especially MRSA, VRE and C. difficile. Clinical Infectious Diseases 1996;23(4):43.
34. Mangini E, Segal-Maurer S, Burns J, Avicolli A, Urban C, Mariano N, et al. Impact of contact and droplet precautions on the incidence of hospital-acquired methicillin-resistant Staphylococcus aureus infection. Infection Control and Hospital Epidemiology: the Official Journal of the Society of Hospital Epidemiologists of America 2007;28(11):1261-6.
35. Marshall C, McBryde E, Richards M. Do rapid detection and isolation of colonized patients reduce MRSA spread in the intensive care unit?. BMC Proceedings 2011;5(Suppl 6):O88.
36. Marshall C, Richards M, McBryde E. Do active surveillance and contact precautions reduce MRSA acquisition? A prospective interrupted time series. PloS one 2013;8(3):e58112.
37. Matsumoto K, Shigemi A, Yaji K, Shimodozono Y, Takeda Y, Ikawa K, et al. Reduction in the incidence of MRSA with use of alcohol-based hand rub solutions and gloves. Journal of Infection and Chemotherapy: Official Journal of the Japan Society of Chemotherapy 2012;18(2):269-71.
38. Matsushima A, Tasaki O, Tomono K, Ogura H, Kuwagata Y, Sugimoto H, et al. Pre-emptive contact precautions for intubated patients reduced healthcare-associated meticillin-resistant Staphylococcus aureus transmission and infection in an intensive care unit. The Journal of Hospital Infection 2011;78(2):97-101.
39. Moore G, Ali S, FitzGerald G, Muzslay M, Atkinson S, Smith S, et al. Ward assessment of SmartIdeas Project: bringing source isolation to the patient. The Journal of Hospital Infection 2010;76(2):103-7.
40. Morioka I, Yahata M, Shibata A, Miwa A, Yokota T, Jikimoto T, et al. Impact of pre-emptive contact precautions for outborn neonates on the incidence of healthcare-associated meticillin-resistant Staphylococcus aureus transmission in a Japanese neonatal intensive care unit. The Journal of Hospital Infection 2013;84(1):66-70.
41. Derde LPG, Cooper B, Brun Buisson C, Bonten M. Mastering hospital antibiotic resistance (mosar): a European cluster-randomized trial on reducing acquisition of resistant bacteria in intensive care units. 25th Annual Congress of the European Society of Intensive Care Medicine, ESICM 2012 Lisbon, Portugal. www.esicm.org/flash-conferences/lisbon-2012 (accessed 7 December 2014).
42. Derde LPG, Cooper BS, Brun-Buisson C, Bonten MJM. Reducing acquisition of resistant bacteria in intensive cares: a European cluster randomised trial. 22nd European Congress of Clinical Microbiology and Infectious Diseases. London, United Kingdom. http://registration.akm.ch/einsicht.php?XNABSTRACT_ID=151880&XNSPRACHE_ID=2&XNKONGRESS_ID=161&XNMASKEN_ID=900 (accessed 7 December 2014).
43. Derde LPG, Cooper BS, Goossens H, Malhotra-Kumar S, Willems RJ, Gniadkowski M, et al. Interventions to reduce colonisation and transmission of antimicrobial-resistant bacteria in intensive care units: an interrupted time series study and cluster randomised trial. The Lancet Infectious Diseases 2014;14(1):31-9.
44. Moylan JA, Fitzpatrick KT, Davenport KE. Reducing wound infections. Improved gown and drape barrier performance. Archives of Surgery (Chicago, Ill.: 1960) 1987;122(2):152-7.
45. Muroya T, Tasaki O, Irisawa T, Shiozaki T, Ogura H, Kuwagata Y, et al. The effect of preemptive contact precaution for intubated patients on the nosocomial infection of MRSA in intensive care unit. Society of Critical Care Medicine's 39TH Critical Care Congress. Critical Care Medicine 2009;37(12 Suppl):S41.
46. Raad II, Hohn DC, Gilbreath BJ, Suleiman N, Hill LA, Bruso PA, et al. Prevention of central venous catheter-related infections by using maximal sterile barrier precautions during insertion. Infection Control and Hospital Epidemiology: the Official Journal of the Society of Hospital Epidemiologists of America 1994;15(4 Pt 1):231-8.
47. Reitzel RA, Dvorak TL, Hachem RY, Fang X, Jiang Y, Raad I. Efficacy of novel antimicrobial gloves impregnated with antiseptic dyes in preventing the adherence of multidrug-resistant nosocomial pathogens. American Journal of Infection Control 2009;37(4):294-300.
48. Ribner BS, Landry MN, Gholson GL. Strict versus modified isolation for prevention of nosocomial transmission of methicillin-resistant Staphylococcus aureus. Infection Control 1986;7(6):317-20.
49. Rijnders BJ, Van Wijngaerden E, Wilmer A, Peetermans WE. Use of full sterile barrier precautions during insertion of arterial catheters: a randomized trial. Clinical Infectious Diseases: an Official Publication of the Infectious Diseases Society of America 2003;36(6):743-8.
50. Rodríguez-Baño J, García L, Ramírez E, Lupion C, Muniain MA, Velasco C, et al. Long-term control of endemic hospital-wide methicillin-resistant Staphylococcus aureus (MRSA): the impact of targeted active surveillance for MRSA in patients and healthcare workers. Infection Control and Hospital Epidemiology: the Official Journal of the Society of Hospital Epidemiologists of America 2010;31(8):786-95.
51. Shenoy ES, Kim J, Rosenberg ES, Cotter JA, Lee H, Walensky RP, et al. Discontinuation of contact precautions for methicillin-resistant staphylococcus aureus: a randomized controlled trial comparing passive and active screening with culture and polymerase chain reaction. Clinical Infectious Diseases: an Official Publication of the Infectious Diseases Society of America 2013;57(2):176-84.
52. Slaughter S, Hayden MK, Nathan C, Hu TC, Rice T, Van Voorhis J, et al. A comparison of the effect of universal use of gloves and gowns with that of glove use alone on acquisition of vancomycin-resistant enterococci in a medical intensive care unit. Annals of Internal Medicine 1996;125(6):448-56.
53. Slota M, Green M, Farley A, Janosky J, Carcillo J. The role of gown and glove isolation and strict handwashing in the reduction of nosocomial infection in children with solid organ transplantation. Critical Care Medicine 2001;29(2):405-12.
54. Spence MR, Dammel T, Courser S. Contact precautions for methicillin-resistant Staphylococcus aureus colonization: costly and unnecessary?. American Journal of Infection Control 2012;40(6):535-8.
55. Huskins WC, Huckabee CM, O'Grady NP, Murray P, Kopetskie H, Zimmer L, et al. Intervention to reduce transmission of resistant bacteria in intensive care. The New England Journal of Medicine 2011;364(15):1407-18.
56. Trick WE, Weinstein RA, DeMarais PL, Tomaska W, Nathan C, McAllister SK, et al. Comparison of routine glove use and contact-isolation precautions to prevent transmission of multidrug-resistant bacteria in a long-term care facility. Journal of the American Geriatrics Society 2004;52(12):2003-9.
57. Trick WE, Vernon MO, Welbel SF, Demarais P, Hayden MK, Weinstein RA. Multicenter intervention program to increase adherence to hand hygiene recommendations and glove use and to reduce the incidence of antimicrobial resistance. Infection Control and Hospital Epidemiology: the Official Journal of the Society of Hospital Epidemiologists of America 2007;28(1):42-9.
58. Williams C, McGraw P, Schneck EE, LaFae A, Jacob JT, Moreno D, et al. Impact of universal gowning and gloving on health care worker clothing contamination. Infection Control and Hospital Epidemiology 2015;36(4):431-7.
59. Yin J, Schweizer ML, Herwaldt LA, Pottinger JM, Perencevich EN. Benefits of universal gloving on hospital-acquired infections in acute care pediatric units. Pediatrics 2013;131(5):e1515-20.
60. Aboelela SW, Saiman L, Stone P, Lowy FD, Quiros D, Larson E. Effectiveness of barrier precautions and surveillance cultures to control transmission of multidrug-resistant organisms: a systematic review of the literature. American Journal of Infection Control 2006;34(8):484-94.
61. Agency for Healthcare Research and Quality. Making health care safer II: an updated critical analysis of the evidence for patient safety practices. Available from: www.ahrq.gov/research/findings/evidence-based-reports/ptsafetyuptp.html (accessed 21 July 2014) 2013.
62. Albrich WC, Harbarth S. Health-care workers: source, vector, or victim of MRSA?. The Lancet Infectious Diseases 2008;8(5):289-301.
63. The Association for Professionals in Infection Control and Epidemiology (APIC). Guide to the elimination of Methicillin-Resistant Staphylococcus aureus (MRSA) transmission in hospital settings, 2nd Edition. http://apic.org/Resource:/EliminationGuideForm/631fcd91-8773-4067-9f85-ab2a5b157eab/File/MRSA-elimination-guide-2010.pdf (accessed 26 May 2014).
64. Arnow P, Allyn PA, Nichols EM, Hill DL, Pezzlo M, Bartlett RH. Control of methicillin-resistant Staphylococcus aureus in a burn unit: role of nurse staffing. The Journal of Trauma 1982;22(11):954-9.
65. Backman C, Taylor G, Sales A, Marck PB. An integrative review of infection prevention and control programs for multidrug-resistant organisms in acute care hospitals: a socio-ecological perspective. American Journal of Infection Control 2011;39(5):368-78.
66. Baker SE, Brecher SM, Robillard E, Strymish J, Lawler E, Gupta K. Extranasal methicillin-resistant Staphylococcus aureus colonization at admission to an acute care Veterans Affairs hospital. Infection Control and Hospital Epidemiology: the Official Journal of the Society of Hospital Epidemiologists of America 2010;31(1):42-6.
67. Barrett FF, McGehee RF Jr, Finland M. Methicillin-resistant Staphylococcus aureus at Boston City Hospital. Bacteriologic and epidemiologic observations. The New England Journal of Medicine 1968;279(9):441-8.
68. Benner EJ, Kayser FH. Growing clinical significance of methicillin-resistant Staphylococcus aureus. Lancet 1968;2(7571):741-4.
69. Bisaga A, Paquette K, Sabatini L, Lovell EO. A prevalence study of methicillin-resistant Staphylococcus aureus colonization in emergency department health care workers. Annals of Emergency Medicine 2008;52(5):525-8.
70. Bland JM, Altman DG. Some examples of regression towards the mean. BMJ (Clinical Research Ed.) 1994;309(6957):780.
71. Blok HE, Troelstra A, Kamp-Hopmans TE, Gigengack-Baars AC, Vandenbroucke-Grauls CM, Weersink AJ, et al. Role of healthcare workers in outbreaks of methicillin-resistant Staphylococcus aureus: a 10-year evaluation from a Dutch university hospital. Infection Control and Hospital Epidemiology: the Official Journal of the Society of Hospital Epidemiologists of America 2003;24(9):679-85.
72. Borenstein M, Hedges LV, Higgins JPT, Rothstein HR. Fixed-effect versus random-effects models. Introduction to Meta-Analysis. Chichester: John Wiley & Sons, Ltd, 2009:77-86.
73. Boutron I, Moher D, Tugwell P, Giraudeauf B, Poiraudeaug S, Nizardh R, et al. A checklist to evaluate a report of a non pharmacological trial (CLEAR NPT) was developed using consensus. Journal of Clinical Epidemiology 2005;58(12):1233-40.
74. Boutron I, Moher D, Altman DG, Schulz KF, Ravaud P. Extending the CONSORT statement to randomized trials of nonpharmacologic treatment: explanation and elaboration. Annals of Internal Medicine 2008;148(4):295-309.
75. Boutron I, Moher D, Ravaud P. Randomized clinical trials of nonpharmacological treatments. Boca Raton: CRC Press, 2012.
76. Boyce JM, Landry M, Deetz TR, DuPont HL. Epidemiologic studies of an outbreak of nosocomial methicillin-resistant Staphylococcus aureus infections. Infection Control 1981;2(2):110-6.
77. Boyce JM, White RL, Causey WA, Lockwood WR. Burn units as a source of methicillin-resistant Staphylococcus aureus infections. JAMA 1983;249(20):2803-7.
78. Boyce JM. Methicillin-resistant Staphylococcus aureus. Detection, epidemiology, and control measures. Infectious Disease Clinics of North America 1989;3(4):901-13.
79. Boyce JM, Opal SM, Potter-Bynoe G, Medeiros AA. Spread of methicillin-resistant Staphylococcus aureus in a hospital after exposure to a health care worker with chronic sinusitis. Clinical Infectious Diseases 1993;17(3):496-504.
80. Brierley G, Brabyn S, Torgerson D, Watson J. Bias in recruitment to cluster randomized trials: a review of recent publications. Journal of Evaluation in Clinical Practice 2012;18(4):878-86.
81. Brown CA, Lilford RJ. The stepped wedge trial design: a systematic review. BMC Medical Research Methodology 2006;6:54.
82. Brown P, Brunnhuber K, Chalkidou K, Chalmers I, Clarke M, Fenton M, et al. How to formulate research recommendations. BMJ (Clinical Research Ed.) 2006;333(7572):804-6.
83. Brown C, Hofer T, Johal A, Thomson R, Nicholl J, Franklin BD, et al. An epistemology of patient safety research: a framework for study design and interpretation. Part 2. Study design. Quality & Safety in Health Care 2008;17(3):163-9.
84. Burford B, Lewin S, Welch V, Rehfuess E, Waters E. Assessing the applicability of findings in systematic reviews of complex interventions can enhance the utility of reviews for decision making. Journal of Clinical Epidemiology 2013;66(11):1251-61.
85. Burton DC, Edwards JR, Horan TC, Jernigan JA, Fridkin SK. Methicillin-resistant Staphylococcus aureus central line-associated bloodstream infections in US intensive care units, 1997-2007. JAMA 2009;301(7):727-36.
86. Calfee DP, Salgado CD, Milstone AM, Harris AD, Kuhar DT, Moody J, et al. Strategies to prevent methicillin-resistant Staphylococcus aureus transmission and infection in acute care hospitals: 2014 update. Infection Control and Hospital Epidemiology: The Official Journal of the Society of Hospital Epidemiologists of America 2014;35(7):772-96.
87. Campbell MK, Piaggio G, Elbourne DR, Altman DG. Consort 2010 statement: extension to cluster randomised trials. BMJ (Clinical Research Ed.) 2012;345:e5661.
88. Centers for Disease Control and Prevention (CDC). CDC/NHSN surveillance definitions for specific types of infections. CDC NHSN Patient Safety Component (PSC) Manual, 2014. www.cdc.gov/nhsn/pdfs/pscmanual/17pscnosinfdef_current.pdf (accessed 26 May 2014).
89. Centre for Evidence Based Medicine. The PaT Plot Tool, 2009. www.cebm.net/index.aspx?o=4200 (accessed 7 June 2014).
90. Chai LY, Ng TM, Habib AG, Singh K, Kumarasinghe G, Tambyah PA. Paradoxical increase in methicillin-resistant Staphylococcus aureus acquisition rates despite barrier precautions and increased hand washing compliance during an outbreak of severe acute respiratory syndrome. Clinical Infectious Diseases: an Official Publication of the Infectious Diseases Society of America 2005; Vol. 40, issue 4:632-3.
91. Climo MW, Yokoe DS, Warren DK, Perl TM, Bolon M, Herwaldt LA, et al. Effect of daily chlorhexidine bathing on hospital-acquired infection. The New England Journal of Medicine 2013;368(6):533-42.
92. Cohen AL, Calfee D, Fridkin SK, Huang SS, Jernigan JA, Lautenbach E, et al. Recommendations for metrics for multidrug-resistant organisms in healthcare settings: SHEA/HICPAC Position paper. Infection Control and Hospital Epidemiology 2008;29(10):901-13.
93. Coia JE, Duckworth GJ, Edwards DI, Farrington M, Fry C, Humphreys H, et al. Guidelines for the control and prevention of methicillin-resistant Staphylococcus aureus (MRSA) in healthcare facilities. Journal of Hospital Infection 2006;63 Suppl 1:1-44.
94. Coia JE, Ritchie L, Adisesh A, Makison Booth C, Bradley C, Bunyan D, et al. Guidance on the use of respiratory and facial protection equipment. The Journal of Hospital Infection 2013;85(3):170-82.
95. CONSORT Group. CONSORT glossary. www.consort-statement.org/resources/glossary (accessed 4 Sept 2014).
96. Cooper BS, Stone SP, Kibbler CC, Cookson BD, Roberts JA, Medley GF, et al. Systematic review of isolation policies in the hospital management of methicillin-resistant Staphylococcus aureus: a review of the literature with epidemiological and economic modelling. Health Technology Assessment 2003;7:1-194.
97. Cosgrove SE, Sakoulas G, Perencevich EN, Schwaber MJ, Karchmer AW, Carmeli Y. Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: a meta-analysis. Clinical Infectious Diseases 2003;36(1):53-9.
98. Cosgrove SE, Qi Y, Kaye KS, Harbarth S, Karchmer AW, Carmeli Y. The impact of methicillin resistance in Staphylococcus aureus bacteraemia on patient outcomes: mortality, length of stay, and hospital charges. Infection Control and Hospital Epidemiology: the Official Journal of the Society of Hospital Epidemiologists of America 2005;26(2):166-74.
99. Crowcroft NS, Catchpole M. Mortality for methicillin-resistant Staphylococcus aureus in England and Wales: analysis of death certificates. BMJ 2002;325(7377):1390-1.
100. Dantes R, Mu Y, Belflower R, Aragon D, Dumyati G, Harrison LH, et al. National burden of invasive methicillin-resistant Staphylococcus aureus infections, United States, 2011. JAMA Internal Medicine 2013;173(21):1970-8.
101. DavidoffF, Batalden P, Stevens D, Ogrinc G, Mooney S. Publication guidelines for quality improvement in health care: evolution of the SQUIRE project. Quality & Safety in Health Care 2008;17 Suppl 1:i3-9.
102. Davis KA, Stewart JJ, Crouch HK, Florez CE, Hospenthal DR. Methicillin-resistant Staphylococcus aureus (MRSA) nares colonization at hospital admission and its effect on subsequent MRSA infection. Clinical Infectious Diseases: an Official Publication of the Infectious Diseases Society of America 2004;39(6):776-82.
103. Day HR, Morgan DJ, Himelhoch S, Young A, Perencevich EN. Association between depression and contact precautions in veterans at hospital admission. American Journal of Infection Control 2011;39(2):163-5.
104. Deeks JJ, Dinnes J, D'Amico R, Sowden AJ, Sakarovitch C, Song F, et al. Evaluating non-randomised intervention studies. Health Technology Assessment (Winchester, England) 2003;7(27):iii-x, 1-173.
105. Deeks JJ, Higgins JPT, Altman DG (editors). Chapter 9: Analysing data and undertaking meta-analyses. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
106. den Heijer CD, van Bijnen EM, Paget WJ, Pringle M, Goossens H, Bruggeman CA, et al. Prevalence and resistance of commensal Staphylococcus aureus, including meticillin-resistant S aureus, in nine European countries: a cross-sectional study. Lancet Infectious Diseases 2013;13(5):409-15.
107. Devine J, Cooke RP, Wright EP. Is methicillin-resistant Staphylococcus aureus (MRSA) contamination of ward-based computer terminals a surrogate marker for nosocomial MRSA transmission and handwashing compliance?. Journal of Hospital Infection 2001;48(1):72-5.
108. European Centre for Disease Prevention and Control (ECDC). Annual epidemiological report. Reporting on 2011 surveillance data and 2012 epidemic intelligence data. 2013. www.ecdc.europa.eu/en/publications/_layouts/forms/Publication_DispForm.aspx?List=4f55ad51-4aed-4d32-b960-af70113dbb90&ID=989 (accessed 26 May 2014).
109. Elie-Turenne MC, Fernandes H, Mediavilla JR, Rosenthal M, Mathema B, Singh A, et al. Prevalence and characteristics of Staphylococcus aureus colonization among healthcare professionals in an urban teaching hospital. Infection Control and Hospital Epidemiology: the Official Journal of the Society of Hospital Epidemiologists of America 2010;31(6):574-80.
110. Engemann JJ, Carmeli Y, Cosgrove SE, Fowler VG, Bronstein MZ, Trivette SL, et al. Adverse clinical and economic outcomes attributable to methicillin resistance among patients with Staphylococcus aureus surgical site infection. Clinical Infectious Diseases 2003;36(5):592-8.
111. Cochrane Effective Practice and Organisation of Care Group (EPOC). Which study designs are accepted for inclusion in EPOC reviews? 2007. http://epoc.cochrane.org/sites/epoc.cochrane.org/files/uploads/FAQ%20-%20Included%20Studies%20-%20EPOC%20-%202007-May-01.doc (accessed 1 June 2014).
112. Cochrane Effective Practice and Organisation of Care Group (EPOC). The data collection checklist. Ottawa, 2009. http://epoc.cochrane.org/sites/epoc.cochrane.org/files/uploads/datacollectionchecklist.pdf (accessed 31 May 2014).
113. Effective Practice, Organisation of Care (EPOC). EPOC Resources for review authors. What study designs should be included in an EPOC review and what should they be called? Oslo: Norwegian Knowledge Centre for the Health Services; 2013. Available from: http://epocoslo.cochrane.org/epoc-specific-resources-review-authors (accessed 7 June 2014).
114. Effective Practice, Organisation of Care (EPOC). EPOC Resources for review authors. Good practice data extraction form. Oslo: Norwegian Knowledge Centre for the Health Services; 2013. Available at: http://epoc.cochrane.org/sites/epoc.cochrane.org/files/uploads/13a%20Good%20practice%20data%20extraction%20form%202013%2008%2012.doc (accessed 7 June 2014).
115. Effective Practice, Organisation of Care (EPOC). EPOC Resources for review authors. Suggested risk of bias criteria for EPOC reviews. Oslo: Norwegian Knowledge Centre for the Health Services; 2013. Available at: http://epoc.cochrane.org/sites/epoc.cochrane.org/files/uploads/14%20Suggested%20risk%20of%20bias%20criteria%20for%20EPOC%20reviews%202013%2008%2012.pdf (accessed 7 June 2014).
116. Effective Practice, Organisation of Care (EPOC). EPOC Resources for review authors. Analysis in EPOC reviews. Oslo: Norwegian Knowledge Centre for the Health Services; 2013. Available at: http://epoc.cochrane.org/sites/epoc.cochrane.org/files/uploads/19%20Analysis%20in%20EPOC%20reviews%202013%2008%2012.pdf (accessed 13 June 2014).
117. Campbell & Cochrane Equity Methods Group. The equity checklist. http://equity.cochrane.org/sites/equity.cochrane.org/files/uploads/EquityChecklist2012.pdf (assessed 15 July 2014).
118. Evans HL, Shaffer MM, Hughes MG, Smith RL, Chong TW, Raymond DP, et al. Contact isolation in surgical patients: a barrier to care?. Surgery 2003;134(2):180-8.
119. US Food, Drug Administration. Guidance for Industry and FDA Staff: Medical Glove Guidance Manual, 2008. www.fda.gov/MedicalDevices/DeviceRegulationandGuidance/GuidanceDocuments/ucm150053.htm (accessed 29 May 2014).
120. US Food, Drug Administration. Devices@FDA: Patient examination glove. www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/cfrsearch.cfm?fr=880.6250 (accessed 29 May 2014).
121. US Food, Drug Administration. Devices@FDA: Surgeońs glove. www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/cfrsearch.cfm?fr=878.4460 (accessed 29 May 2014).
122. Fridkin SK, Hill HA, Volkova NV, Edwards JR, Lawton RM, Gaynes RP, et al. Temporal changes in prevalence of antimicrobial resistance in 23 US hospitals. Emerging Infectious Diseases 2002;8(7):697-701.
123. Fuller C, Savage J, Besser S, Hayward A, Cookson B, Cooper B, et al. "The dirty hand in the latex glove": a study of hand hygiene compliance when gloves are worn. Infection Control and Hospital Epidemiology: the Official Journal of the Society of Hospital Epidemiologists of America 2011;32(12):1194-9.
124. Gamble C, Hollis S. Uncertainty method improved on best-worst case analysis in a binary meta-analysis. Journal of Clinical Epidemiology 2005;58(6):579-88.
125. Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM. CDC definitions for nosocomial infections. In: Olmsted RN editor(s). APIC Infection Control and Applied Epidemiology: Principles and Practice. St. Louis: Mosby, 1996:A1-A20.
126. Gastmeier P, Schwab F, Geffers C, Ruden H. To isolate or not to isolate? Analysis of data from the German Nosocomial Infection Surveillance System regarding the placement of patients with methicillin-resistant Staphylococcus aureus in private rooms in intensive care units. Infection Control and Hospital Epidemiology: the Official Journal of the Society of Hospital Epidemiologists of America 2004;25(2):109-13.
127. Gaynes R, Marosok R, Mowry-Hanley J, Laughlin C, Foley K, Friedman C, et al. Mediastinitis following coronary artery bypass surgery: a 3-year review. Journal of Infectious Diseases 1991;163(1):117-21.
128. Girou E, Chai S H, Oppein F, Legrand P, Ducellier D, Cizeau F, et al. Misuse of gloves: the foundation for poor compliance with hand hygiene and potential for microbial transmission?. The Journal of Hospital Infection 2004;57(2):162-9.
129. Glick SB, Samson DJ, Huang E, Vats V, Weber S, Aronson N. Screening for methicillin-resistant Staphylococcus aureus (MRSA). Rockville (MD): Agency for Healthcare Research and Quality (AHRQ); 2013 June. Comparative effectiveness review No. 102. AHRQ Publication No. 13-EHC043-EF.
130. Goetghebeur M, Landry PA, Han D, Vicente C. Methicillin-resistant Staphylococcus aureus: a public health issue with economic consequences. Canadian Journal of Infectious Diseases & Medical Microbiology [Journal Canadien des Maladies Infectieuses et de la Microbiologie Medicale] 2007;18(1):27-34.
131. Golder S, Loke Y. Search strategies to identify information on adverse effects: a systematic review. Journal of the Medical Library Association: JMLA 2009;97(2):84-92.
132. Gorwitz RJ, Kruszon-Moran D, McAllister SK, McQuillan G, McDougal LK, Fosheim GE, et al. Changes in the prevalence of nasal colonization with Staphylococcus aureus in the United States, 2001-2004. The Journal of Infectious Diseases 2008;197(9):1226-34.
133. Gould IM. Costs of hospital-acquired methicillin-resistant Staphylococcus aureus (MRSA) and its control. International Journal of Antimicrobial Agents 2006;28(5):379-84.
134. Gould FK, Brindle R, Chadwick PR, Fraise AP, Hill S, Nathwani D, et al. Guidelines (2008) for the prophylaxis and treatment of methicillin-resistant Staphylococcus aureus (MRSA) infections in the United Kingdom. The Journal of Antimicrobial Chemotherapy 2009;63(5):849-61.
135. Gould I, Reilly J, Bunyan D, Walker A. Costs of healthcare associated methicillin-resistant Staphylococcus aureus (MRSA) and its control. Clinical Microbiology and Infection: the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2010;16(12):1721-8.
136. McMaster University. GRADEpro. 3.2 for Windows. McMaster University, 2014.
137. Grimes DA, Schulz KF. Descriptive studies: what they can and cannot do. Lancet 2002;359(9301):145-9.
138. Grundmann H, Aires-de-Sousa M, Boyce J. Emergence and resurgence of meticillin-resistant Staphylococcus aureus as a public-health threat. Lancet 2006;368(9538):874-85.
139. Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P, et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ 2008;336:924-6.
140. Hails J, Kwaku F, Wilson AP, Bellingan G, Singer M. Large variation in MRSA policies, procedures and prevalence in English intensive care units: a questionnaire analysis. Intensive Care Medicine 2003;29(3):481-3.
141. Halcomb EJ, Fernandez R, Griffiths R, Newton RN, Hickman L. The infection control management of MRSA in acute care. International Journal of Evidence-based Healthcare 2008;6:440-67.
142. Hansen S, Schwab F, Asensio A, Carsauw H, Heczko P, Klavs I, et al. Methicillin-resistant Staphylococcus aureus (MRSA) in Europe: which infection control measures are taken?. Infection 2010;38(3):159-64.
143. Harbarth S, Fankhauser C, Schrenzel J, Christenson J, Gervaz P, Bandiera-Clerc C, et al. Universal screening for methicillin-resistant Staphylococcus aureus at hospital admission and nosocomial infection in surgical patients. JAMA 2008;299(10):1149-57.
144. Harris AD, Bradham DD, Baumgarten M, Zuckerman IH, Fink JC, Perencevich EN. The use and interpretation of quasi-experimental studies in infectious diseases. Clinical Infectious Diseases: an Official Publication of the Infectious Diseases Society of America 2004;38(11):1586-91.
145. Hartling L, Bond K, Harvey K, Santaguida PL, Viswananthan M, Dryden DM. Developing and testing a tool for the classification of study designs in systematic reviews of interventions and exposures, 2010. Agency for Healthcare Research and Quality; Methods Research Report. AHRQ Publication No. 11-EHC-007. Available at http://effectivehealthcare.ahrq.gov/(accessed 29 May 2014).
146. Hartman B, Tomasz A. Altered penicillin-binding proteins in methicillin-resistant strains of Staphylococcus aureus. Antimicrobial Agents and Chemotherapy 1981;19(5):726-35.
147. Hartstein AI, Denny MA, Morthland VH, LeMonte AM, Pfaller MA. Control of methicillin-resistant Staphylococcus aureus in a hospital and an intensive care unit. Infection Control and Hospital Epidemiology: the Official Journal of the Society of Hospital Epidemiologists of America 1995;16(7):405-11.
148. Hayes RJ, Alexander ND, Bennett S, Cousens SN. Design and analysis issues in cluster-randomized trials of interventions against infectious diseases. Statistical Methods in Medical Research 2000;9(2):95-116.
149. Hidron AI, Kourbatova EV, Halvosa JS, Terrell BJ, McDougal LK, Tenover FC, et al. Risk factors for colonization with methicillin-resistant Staphylococcus aureus (MRSA) in patients admitted to an urban hospital: emergence of community-associated MRSA nasal carriage. Clinical Infectious Diseases: an Official Publication of the Infectious Diseases Society of America 2005;41(2):159-66.
150. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ (Clinical Research Ed.) 2003;327(7414):557-60.
151. Higgins JPT, Green S (editors). Glossary of Cochrane Collaboration Version 4.2.5 [updated in May 2005]. The Cochrane Collaboration, 2005. www.cochrane.org/glossary (accessed 20 May 2014).
152. Higgins JPT, Altman DG, Sterne JAC (editors). Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
153. Higgins JPT, Deeks JJ, Altman DG (editors). Chapter 16: Special topics in statistics. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
154. Higgins JPT, Deeks JJ (editors). Chapter 7: Selecting studies and collecting data. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
155. Hoffmann TC, Glasziou PP, Boutron I, Milne R, Perera R, Moher D, et al. Better reporting of interventions: template for intervention description and replication (TIDieR) checklist and guide. BMJ (Clinical Research Ed.) 2014;348:g1687.
156. Huang SS, Platt R. Risk of methicillin-resistant Staphylococcus aureus infection after previous infection or colonization. Clinical Infectious Diseases: an Official Publication of the Infectious Diseases Society of America 2003;36(3):281-5.
157. Hughes C, Tunney M, Bradley MC. Infection control strategies for preventing the transmission of meticillin-resistant Staphylococcus aureus (MRSA) in nursing homes for older people. Cochrane Database of Systematic Reviews 2013, Issue 11. [DOI: 10.1002/14651858.CD006354.pub4]
158. Institute for Healthcare Improvement. Raising the bar with bundles: treating patients with an all-or-nothing standard, 2006. www.ihi.org/resources/Pages/Publications/RaisingtheBarwithBundles.aspx (accessed 31 August 2014).
159. Ijaz S, Verbeek JH, Mischke C, Ruotsalainen J. Inclusion of nonrandomized studies in Cochrane systematic reviews was found to be in need of improvement. Journal of Clinical Epidemiology 2014;67(6):645-53.
160. Ioannidis JP, Evans SJ, Gotzsche PC, O'Neill RT, Altman DG, Schulz K, et al. Better reporting of harms in randomized trials: an extension of the CONSORT statement. Annals of Internal Medicine 2004;141(10):781-8.
161. Ioannidis JP, Prasad V. Evaluating health system processes with randomized controlled trials. JAMA Internal Medicine 2013;173(14):1279-80.
162. Irish Department of Health. Prevention and control methicillin-resistant Staphylococcus aureus (MRSA) national clinical guideline. National Clinical Guideline No. 2, 2013. www.dohc.ie/publications/MRSA_Guideline.html (accessed 26 May 2014).
163. Iwamoto M, Mu Y, Lynfield R, Bulens SN, Nadle J, Aragon D, et al. Trends in invasive methicillin-resistant Staphylococcus aureus infections. Pediatrics 2013;132(4):e817-24.
164. Jarvis WR, Schlosser J, Chinn RY, Tweeten S, Jackson M. National prevalence of methicillin-resistant Staphylococcus aureus in inpatients at US health care facilities, 2006. American Journal of Infection Control 2007;35(10):631-7.
165. Jefferson T, Del Mar CB, Dooley L, Ferroni E, Al-Ansary LA, Bawazeer GA, et al. Physical interventions to interrupt or reduce the spread of respiratory viruses. Cochrane Database of Systematic Reviews 2011, Issue 7. [DOI: 10.1002/14651858.CD006207.pub4]
166. Jernigan JA, Titus MG, Groschel DH, Getchell-White S, Farr BM. Effectiveness of contact isolation during a hospital outbreak of methicillin-resistant Staphylococcus aureus. American Journal of Epidemiology 1996;143(5):496-504.
167. Johnson S, Gerding DN, Olson MM, Weiler MD, Hughes RA, Clabots CR, et al. Prospective, controlled study of vinyl glove use to interrupt Clostridium difficile nosocomial transmission. The American Journal of Medicine 1990;88(2):137-40.
168. Johnston BL, Bryce E. Hospital infection control strategies for vancomycin-resistant Enterococcus, methicillin-resistant Staphylococcus aureus and Clostridium difficile. Canadian Medical Association Journal 2009;180(6):627-31.
169. Kallen AJ, Mu Y, Bulens S, Reingold A, Petit S, Gershman K, et al. Health care-associated invasive MRSA infections, 2005-2008. JAMA 2010;304(6):641-8.
170. Karchmer TB, Durbin LJ, Simonton BM, Farr BM. Cost-effectiveness of active surveillance cultures and contact/droplet precautions for control of methicillin-resistant Staphylococcus aureus. The Journal of Hospital Infection 2002;51(2):126-32.
171. Karki S, Leder K, Cheng A C. Patients under contact precautions have an increased risk of injuries and medication errors: a retrospective cohort study. Infection Control and Hospital Epidemiology: the Official Journal of the Society of Hospital Epidemiologists of America 2013;34(10):1118-20.
172. Kypraios T, O'Neill PD, Huang SS, Rifas-Shiman SL, Cooper BS. Assessing the role of undetected colonization and isolation precautions in reducing methicillin-resistant Staphylococcus aureus transmission in intensive care units. BMC Infectious Diseases 2010;10:29.
173. Leclair JM, Freeman J, Sullivan BF, Crowley CM, Goldmann DA. Prevention of nosocomial respiratory syncytial virus infections through compliance with glove and gown isolation precautions. The New England Journal of Medicine 1987;317(6):329-34.
174. Lee AS, Huttner B, Harbarth S. Control of methicillin-resistant Staphylococcus aureus. Infectious Disease Clinics of North America 2011;25(1):155-79.
175. Lee BY, Singh A, Bartsch SM, Wong KF, Kim DS, Avery TR, et al. The potential regional impact of contact precaution use in nursing homes to control methicillin-resistant Staphylococcus aureus. Infection Control and Hospital Epidemiology: the Official Journal of the Society of Hospital Epidemiologists of America 2013;34(2):151-60.
176. Lefebvre C, Manheimer E, Glanville J. Chapter 6: Searching for studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
177. Liberati A, Altman DG, TetzlaffJ, Mulrow C, Gotzsche PC, Ioannidis JP, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS medicine 2009;6(7):e1000100.
178. Lin MY, Bonten MJ. The dilemma of assessment bias in infection control research. Clinical Infectious Diseases: an Official Publication of the Infectious Diseases Society of America 2012;54(9):1342-7.
179. Lipp A, Edwards P. Disposable surgical face masks for preventing surgical wound infection in clean surgery. Cochrane Database of Systematic Reviews 2014, Issue 2. [DOI: 10.1002/14651858.CD002929.pub2]
180. Livermore DM. Antibiotic resistance in staphylococci. International Journal of Antimicrobial Agents 2000;16 Suppl 1:3-10.
181. Loeb M, Main C, Walker-Dilks C, Eady A. Antimicrobial drugs for treating methicillin-resistant Staphylococcus aureus colonization. Cochrane Database of Systematic Reviews 2003, Issue 4. [DOI: 10.1002/14651858.CD003340]
182. Loke YK, Price D, Herxheimer A. Chapter 14: Adverse effects. In: Higgins JPT, Green S (editors), Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
183. Loveday HP, Pellowe CM, Jones SR, Pratt RJ. A systematic review of the evidence for interventions for the prevention and control of meticillin-resistant Staphylococcus aureus (1996-2004): report to the Joint MRSA Working Party (Subgroup A). The Journal of Hospital Infection 2006;63 Suppl 1:S45-70.
184. Loveday HP, Wilson JA, Pratt RJ, Golsorkhi M, Tingle A, Bak A, et al. epic3: national evidence-based guidelines for preventing healthcare-associated infections in NHS hospitals in England. The Journal of Hospital Infection 2014;86 Suppl 1:S1-70.
185. Magill SS, Edwards JR, Bamberg W, Beldavs ZG, Dumyati G, Kainer MA, et al. Multistate point-prevalence survey of health care-associated infections. The New England Journal of Medicine 2014;370(13):1198-208.
186. McKinnell JA, Miller LG, Eells SJ, Cui E, Huang SS. A systematic literature review and meta-analysis of factors associated with methicillin-resistant Staphylococcus aureus colonization at time of hospital or intensive care unit admission. Infection Control and Hospital Epidemiology: the Official Journal of the Society of Hospital Epidemiologists of America 2013;34(10):1077-86.
187. Chandler J, Churchill R, Higgins J, Lasserson T, Tovey D. Methodological standards for the conduct of new Cochrane intervention reviews, 2013. www.editorial-unit.cochrane.org/sites/editorial-unit.cochrane.org/files/uploads/MECIR_conduct_standards%202.3%2002122013.pdf (accessed 7 June 2014).
188. Mehrotra P, Croft L, Day HR, Perencevich EN, Pineles L, Harris AD, et al. Effects of contact precautions on patient perception of care and satisfaction: a prospective cohort study. Infection Control and Hospital Epidemiology: the Official Journal of the Society of Hospital Epidemiologists of America 2013;34(10):1087-93.
189. Merrer J, Santoli F, Appere de Vecchi C, Tran B, De Jonghe B, Outin H. "Colonization pressure" and risk of acquisition of methicillin-resistant Staphylococcus aureus in a medical intensive care unit. Infection Control and Hospital Epidemiology: the Official Journal of the Society of Hospital Epidemiologists of America 2000;21(11):718-23.
190. Mertz D, Frei R, Periat N, Zimmerli M, Battegay M, Fluckiger U, et al. Exclusive Staphylococcus aureus throat carriage: at-risk populations. Archives of Internal Medicine 2009;169(2):172-8.
191. US National Library of Medicine. MeSH Browser (2014 MeSH). www.ncbi.nlm.nih.gov/mesh (accessed 28 May 2014).
192. Mischke C, Verbeek JH, Saarto A, Lavoie MC, Pahwa M, Ijaz S. Gloves, extra gloves or special types of gloves for preventing percutaneous exposure injuries in healthcare personnel. Cochrane Database of Systematic Reviews 2014, Issue 3. [DOI: 10.1002/14651858.CD009573.pub2]
193. Morgan DJ, Diekema DJ, Sepkowitz K, Perencevich EN. Adverse outcomes associated with contact precautions: a review of the literature. American Journal of Infection Control 2009;37(2):85-93.
194. Morgan DJ, Day HR, Furuno JP, Young A, Johnson JK, Bradham DD, et al. Improving efficiency in active surveillance for methicillin-resistant Staphylococcus aureus or vancomycin-resistant Enterococcus at hospital admission. Infection Control and Hospital Epidemiology: the Official Journal of the Society of Hospital Epidemiologists of America 2010;31(12):1230-5.
195. Morgan DJ, Day HR, Harris AD, Furuno JP, Perencevich EN. The impact of contact isolation on the quality of inpatient hospital care. PLoS One 2011;6(7):e22190.
196. Morton V, Torgerson DJ. Effect of regression to the mean on decision making in health care. BMJ (Clinical Research Ed.) 2003;326(7398):1083-4.
197. Medical Research Council. Developing and evaluating complex interventions: new guidance, 2008. www.mrc.ac.uk/complexinterventionsguidance (accessed 7 July 2014).
198. Muto CA, Jernigan JA, Ostrowsky BE, Richet HM, Jarvis WR, Boyce JM, et al. SHEA guideline for preventing nosocomial transmission of multidrug-resistant strains of Staphylococcus aureus and Enterococcus. Infection Control and Hospital Epidemiology: the Official Journal of the Society of Hospital Epidemiologists of America 2003;24(5):362-86.
199. Commonwealth of Australia. Australian guidelines for the prevention and control of infection in healthcare. www.nhmrc.gov.au/_files_nhmrc/publications/attachments/cd33_complete.pdf (accessed 26 May 2014).
200. Noorani HZ, Adams E, Glick S, Weber S, Belinson S, Aronson N. Screening for methicillin-resistant Staphylococcus aureus (MRSA): future research needs. Rockville (MD): Agency for Healthcare Research and Quality (AHRQ); 2013 June. Future research needs paper No. 40. AHRQ Publication No. 13-EHC056-EF.
201. Cochrane Non-Randomised Studies Methods Group. Data extraction for non-randomised studies, 2011. www.cochrane.org/sites/default/files/uploads/data_extraction.doc (accessed 7 May 2014).
202. New Zealand Ministry of Health (NZMoH). Guidelines for the control of methicillin resistant Staphylococcus aureus in New Zealand, 2002. www.health.govt.nz/system/files/documents/publications/mrsa.pdf (accessed 26 May 2014).
203. O'Connor D, Green S, Higgins JPT (editors). Chapter 5: Defining the review question and developing criteria for including studies. In: Higgins JPT, Green S (editors), Cochrane Handbook of Systematic Reviews of Intervention. Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
204. Oie S, Kamiya A. Survival of methicillin-resistant Staphylococcus aureus (MRSA) on naturally contaminated dry mops. Journal of Hospital Infection 1996;34(2):145-9.
205. Olsen RJ, Lynch P, Coyle MB, Cummings J, Bokete T, Stamm WE. Examination gloves as barriers to hand contamination in clinical practice. JAMA 1993;270(3):350-3.
206. Pammi M, Eddama O, Weisman LE. Patient isolation measures for infants with candida colonization or infection for preventing or reducing transmission of candida in neonatal units. Cochrane Database of Systematic Reviews 2011, Issue 11. [DOI: 10.1002/14651858.CD006068.pub3]
207. Pan A, Carnevale G, Catenazzi P, Colombini P, Crema L, Dolcetti L, et al. Trends in methicillin-resistant Staphylococcus aureus (MRSA) bloodstream infections: effect of the MRSA "search and isolate" strategy in a hospital in Italy with hyperendemic MRSA. Infection Control and Hospital Epidemiology: the Official Journal of the Society of Hospital Epidemiologists of America 2005;26(2):127-33.
208. Peacock JE Jr, Marsik FJ, Wenzel RP. Methicillin-resistant Staphylococcus aureus: introduction and spread within a hospital. Annals of Internal Medicine 1980;93(4):526-32.
209. Perera R, Heneghan C, Yudkin P. Graphical method for depicting randomised trials of complex interventions. BMJ 2007;334(7585):127-9.
210. Platt R, Takvorian SU, Septimus E, Hickok J, Moody J, Perlin J, et al. Cluster randomized trials in comparative effectiveness research: randomizing hospitals to test methods for prevention of healthcare-associated infections. Medical Care 2010;48(6 Suppl):S52-7.
211. Pogorzelska M, Stone PW, Larson EL. Wide variation in adoption of screening and infection control interventions for multidrug-resistant organisms: a national study. American Journal of Infection Control 2012;40(8):696-700.
212. Porta M, Greenland S, Last JM. A dictionary of Epidemiology. 5th Edition. New York: Oxford University Press, 2008.
213. Public Health Agency of Canada. Hand hygiene practices in healthcare settings. 2012. www.ipac-canada.org/pdf/2013_PHAC_Hand%20Hygiene-EN.pdf (accessed 8 December 2014).
214. Public Health Agency of Canada. Routine practices and additional precautions: preventing the transmission of infection in health care. 2012. www.ipac-canada.org/pdf/2013_PHAC_RPAP-EN.pdf (accessed 26 May 2014).
215. Puzniak LA, Leet T, Mayfield J, Kollef M, Mundy LM. To gown or not to gown: the effect on acquisition of vancomycin-resistant enterococci. Clinical Infectious Diseases: an Official Publication of the Infectious Diseases Society of America 2002;35(1):18-25.
216. Rammelkamp CH, Mortimer EA, Wolinsky E. Transmission of streptococcal and staphylococcal infections. Annals of Internal Medicine 1964;60:753-8.
217. Ranji SR, Shetty K, Posley KA, Lewis R, Sundaram V, Galvin CM, et al. Volumen 6-Prevention of healthcare-associated infections. Closing the quality gap: a critical analysis of quality improvement strategies. Rockville, MD: Agency for Healthcare Research and Quality, January 2007.
218. Reagan DR, Doebbeling BN, Pfaller MA, Sheetz CT, Houston AK, Hollis RJ, et al. Elimination of coincident Staphylococcus aureus nasal and hand carriage with intranasal application of mupirocin calcium ointment. Annals of Internal Medicine 1991;114(2):101-6.
219. Reboli AC, John JF Jr, Platt CG, Cantey JR. Methicillin-resistant Staphylococcus aureus outbreak at a Veterans' Affairs Medical Center: importance of carriage of the organism by hospital personnel. Infection Control and Hospital Epidemiology: the Official Journal of the Society of Hospital Epidemiologists of America 1990;11(6):291-6.
220. Reeves BC, Deeks JJ, Higgins JPT, Wells GA. Chapter 13: Including non-randomised studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
221. The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014.
222. Rodriguez-Baño J, Millán AB, Domínguez MA, Almirante B, Cercenado E, Padilla B, et al. Control of methicillin-resistant Staphylococcus aureus in Spanish hospitals. A survey from the MRSA 2003 GEIH/GEMARA/REIPI project [Medidas de control de Staphylococcus aureus resistente a meticilina en hospitales españoles. Encuesta del proyecto SARM 2003 GEIH/GEMARA/REIPI.]. Enfermedades Infecciosas y Microbiología Clínica 2006;24(3):149-56.
223. Rutala WA, Katz EB, Sherertz RJ, Sarubbi FA Jr. Environmental study of a methicillin-resistant Staphylococcus aureus epidemic in a burn unit. Journal of Clinical Microbiology 1983;18(3):683-8.
224. Safdar N, Abad C. Educational interventions for prevention of healthcare-associated infection: a systematic review. Critical Care Medicine 2008;36(3):933-40.
225. Safdar N, Anderson DJ, Braun BI, Carling P, Cohen S, Donskey C, et al. The evolving landscape of healthcare-associated infections: recent advances in prevention and a road map for research. Infection Control and Hospital Epidemiology: the Official Journal of the Society of Hospital Epidemiologists of America 2014;35(5):480-93.
226. Sánchez García M, De la Torre MA, Morales G, Peláez B, Tolón MJ, Domingo S, et al. Clinical outbreak of linezolid-resistant Staphylococcus aureus in an intensive care unit. JAMA 2010;303(22):2260-4.
227. Santos RP, Mayo TW, Siegel JD. Healthcare epidemiology: active surveillance cultures and contact precautions for control of multidrug-resistant organisms: ethical considerations. Clinical Infectious Diseases: an Official Publication of the Infectious Diseases Society of America 2008;47(1):110-6.
228. Schlesinger A, Paul M, Gafter-Gvili A, Rubinovitch B, Leibovici L. Infection-control interventions for cancer patients after chemotherapy: a systematic review and meta-analysis. Lancet Infectious Diseases 2009;9(2):97-107.
229. Schulz KF, Altman DG, Moher D, for the CONSORT Group. CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials. BMC Medicine 2010;8:18.
230. Schünemann HJ, Oxman AD, Vist GE, Higgins JPT, Deeks JJ, Glasziou P, Guyatt GH. Chapter 12: Interpreting results and drawing conclusions. In: Higgins JPT, Green S (editors), Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
231. Seibert DJ, Speroni KG, Oh KM, DeVoe MC, Jacobsen KH. Knowledge, perceptions, and practices of methicillin-resistant Staphylococcus aureus transmission prevention among health care workers in acute-care settings. American Journal of Infection Control 2014;42(3):254-9. [PUBMED: 24406259]
232. Selkon JB, Stokes ER, Ingham HR. The role of an isolation unit in the control of hospital infection with methicillin resistant staphylococci. Journal of Hospital Infection 1980;1(1):41-6.
233. Shadish WR, Cook TD, Campbell DT. Experimental and quasi-experimental designs for generalized causal inference. Boston (MA): Houghton Mifflin, 2002.
234. Sheretz RJ, Reagan DR, Hampton KD, Robertson KL, Streed SA, Hoen HM, et al. A cloud adult: the Staphylococcus aureus-virus interaction revisited. Annals of Internal Medicine 1996;124(6):539-47.
235. Shiomori T, Miyamoto H, Makishima K. Significance of airborne transmission of methicillin-resistant Staphylococcus aureus in an otolaryngology-head and neck surgery unit. Archives of Otolaryngology--Head & Neck Surgery 2001;127(6):644-8.
236. Siegel JD, Rhinehart E, Jackson M, Chiarello L, and the Healthcare Infection Control Practices Advisory Committee. Management of multidrug-resistant organisms in healthcare settings, 2006. www.cdc.gov/hicpac/pdf/MDRO/MDROGuideline2006.pdf (accessed 29 May 2014).
237. Siegel JD, Rhinehart E, Jackson M, Chiarello L, and the Healthcare Infection Control Practices Advisory Committee. 2007 Guideline for Isolation Precautions: Preventing Transmission of Infectious Agents in Healthcare Settings. www.cdc.gov/hicpac/pdf/isolation/Isolation2007.pdf (accessed 29 May 2014).
238. Sievert DM, Ricks P, Edwards JR, Schneider A, Patel J, Srinivasan A, et al. Antimicrobial-resistant pathogens associated with healthcare-associated infections: summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2009-2010. Infection Control and Hospital Epidemiology: the Official Journal of the Society of Hospital Epidemiologists of America 2013;34(1):1-14.
239. Scottish Intercollegiate Guidelines Network (SIGN). Search filters. Available from: www.sign.ac.uk/guidelines/fulltext/50/index.html (accessed 31 July 2014).
240. Smith DH, Kramer JM, Perrin N, Platt R, Roblin DW, Lane K, et al. A randomized trial of direct-to-patient communication to enhance adherence to beta-blocker therapy following myocardial infarction. Archives of Internal Medicine 2008;168(5):477-83; discussion 483; quiz 447.
241. Snyder GM, Thom KA, Furuno JP, Perencevich EN, Roghmann MC, Strauss SM, et al. Detection of methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci on the gowns and gloves of healthcare workers. Infection Control and Hospital Epidemiology: the Official Journal of the Society of Hospital Epidemiologists of America 2008;29(7):583-9.
242. Srinivasan M, Uma A, Vinodhkumaradithyaa A, Gomathi S, Thirumalaikolundusubramanian P. The medical overcoat - is it a transmitting agent for bacterial pathogens?. Japanese Journal of Infectious Diseases 2007;60(2-3):121-2.
243. Sterne JAC, Egger M, Moher D (editors). Chapter 10: Addressing reporting biases. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Intervention. Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org. The Cochrane Collaboration, 2008. Available from www.cochrane-handbook.org.
244. Stewart A, Eyers PS, Earnshaw JJ. Prevention of infection in arterial reconstruction. Cochrane Database of Systematic Reviews 2006, Issue 3. [DOI: 10.1002/14651858.CD003073.pub2]
245. Stone SP, Cooper BS, Kibbler CC, Cookson BD, Roberts JA, Medley GF, et al. The ORION statement: guidelines for transparent reporting of outbreak reports and intervention studies of nosocomial infection. Lancet Infectious Diseases 2007;7(4):282-8.
246. Suffoletto BP, Cannon EH, Ilkhanipour K, Yealy DM. Prevalence of Staphylococcus aureus nasal colonization in emergency department personnel. Annals of Emergency Medicine 2008;52(5):529-33.
247. Sunenshine RH, Liedtke LA, Fridkin SK, Strausbaugh LJ. Management of inpatients colonized or infected with antimicrobial-resistant bacteria in hospitals in the United States. Infection Control and Hospital Epidemiology: the Official Journal of the Society of Hospital Epidemiologists of America 2005;26(2):138-43.
248. Tanner J, Parkinson H. Double gloving to reduce surgical cross-infection. Cochrane Database of Systematic Reviews 2006, Issue 3. [DOI: 10.1002/14651858.CD003087.pub2]
249. Tenorio AR, Badri SM, Sahgal NB, Hota B, Matushek M, Hayden MK, et al. Effectiveness of gloves in the prevention of hand carriage of vancomycin-resistant enterococcus species by health care workers after patient care. Clinical Infectious Diseases: an Official Publication of the Infectious Diseases Society of America 2001;32(5):826-9.
250. Thompson RL, Cabezudo I, Wenzel RP. Epidemiology of nosocomial infections caused by methicillin-resistant Staphylococcus aureus. Annals of Internal Medicine 1982;97(3):309-17.
251. Tiemersma EW, Monnet DL, Bruinsma N, Skov R, Monen JC, Grundmann H. Methicillin-resistant Staphylococcus aureus in Europe, 1999-2002. Emerging Infectious Diseases 2004;10(9):1627-34.
252. Troillet N, Carmeli Y, Samore MH, Dakos J, Eichelberger K, DeGirolami PC, et al. Carriage of methicillin-resistant Staphylococcus aureus at hospital admission. Infection Control and Hospital Epidemiology: the Official Journal of the Society of Hospital Epidemiologists of America 1998;19(3):181-5.
253. Turnidge JD, Bell JM. Methicillin-resistant Staphylococcal aureus evolution in Australia over 35 years. Microbial Drug Resistance (Larchmont, NY) 2000;6(3):223-9.
254. Ukoumunne OC, Gulliford MC, Chinn S, Sterne JAC, Burney PGJ. Methods for evaluating area-wide and organisation based interventions in health and health care: a systematic review. Health Technology Assessment 1999;3(5):1-108.
255. Ward TT, Winn RE, Hartstein AI, Sewell DL. Observations relating to an inter-hospital outbreak of methicillin-resistant Staphylococcus aureus: role of antimicrobial therapy in infection control. Infection Control 1981;2(6):453-9.
256. Webster J, Pritchard MA. Gowning by attendants and visitors in newborn nurseries for prevention of neonatal morbidity and mortality. Cochrane Database of Systematic Reviews 2003, Issue 3. [DOI: 10.1002/14651858.CD003670]
257. Welch V. Operating Grant: improving the relevance of randomized controlled trials for equity-oriented decisions. http://equity.cochrane.org/sites/equity.cochrane.org/files/uploads/CONSORT-equity%20application_sept15_tosubmit%20%282%29.pdf (accessed 25 July 2014).
258. Wenzel RP, Reagan DR, Bertino JS Jr, Baron EJ, Arias K. Methicillin-resistant Staphylococcus aureus outbreak: a consensus panel's definition and management guidelines. American Journal of Infection Control 1998;26(2):102-10.
259. Wenzel R P, Edmond M B. Infection control: the case for horizontal rather than vertical interventional programs. International Journal of Infectious Diseases 2010;14 Suppl 4:S3-5.
260. Wertheim HF, Melles DC, Vos MC, van Leeuwen W, van Belkum A, Verbrugh HA, et al. The role of nasal carriage in Staphylococcus aureus infections. Lancet Infectious Diseases 2005;5(12):751-62.
261. World Health Organization. Practical guidelines for infection control in health care facilities. India: World Health Organization, 2004.
262. World Health Organization (WHO). Antimicrobial resistance: global report on surveillance, 2014. www.who.int/drugresistance/documents/surveillancereport/en/(accessed 26 May 2014).
263. Williams RE. Healthy carriage of Staphylococcus aureus: its prevalence and importance. Bacteriological Reviews 1963;27(1):56-71.
264. Williams RE. Epidemiology of airborne staphylococcal infection. Bacteriological Reviews 1966;30(3):660-74.
265. Wilson RD, Huang SJ, McLean AS. The correlation between airborne methicillin-resistant Staphylococcus aureus with the presence of MRSA colonized patients in a general intensive care unit. Anaesthesia and Intensive Care 2004;32(2):202-9.
266. Wilson J, Elgohari S, Livermore DM, Cookson B, Johnson A, Lamagni T, et al. Trends among pathogens reported as causing bacteraemia in England, 2004-2008. Clinical Microbiology and Infection: the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2011;17(3):451-8.
267. Working party on infection prevention. Meticilline-resistente Staphylococcus aureus (MRSA). www.rivm.nl/dsresource?objectid=rivmp:46603&type=org&disposition=inline&ns_nc=1 (accessed 26 May 2014).
268. Yap FH, Gomersall CD, Fung KS, Ho PL, Ho OM, Lam PK, et al. Increase in methicillin-resistant Staphylococcus aureus acquisition rate and change in pathogen pattern associated with an outbreak of severe acute respiratory syndrome. Clinical Infectious Diseases: an Official Publication of the Infectious Diseases Society of America 2004;39(4):511-6.
269. Zachary KC, Bayne PS, Morrison VJ, Ford DS, Silver LC, Hooper DC. Contamination of gowns, gloves, and stethoscopes with vancomycin-resistant enterococci. Infection Control and Hospital Epidemiology: the Official Journal of the Society of Hospital Epidemiologists of America 2001;22(9):560-4.
270. Zahar JR, Garrouste-Orgeas M, Vesin A, Schwebel C, Bonadona A, Philippart F, et al. Impact of contact isolation for multidrug-resistant organisms on the occurrence of medical errors and adverse events. Intensive Care Medicine 2013;39(12):2153-60.
271. Zastrow RL. Emerging infections: the contact precautions controversy. The American Journal of Nursing 2011;111(3):47-53.
272. Ziakas PD, Anagnostou T, Mylonakis E. The prevalence and significance of methicillin-resistant Staphylococcus aureus colonization at admission in the general ICU Setting: a meta-analysis of published studies. Critical Care Medicine 2014;42(2):433-44.